| Literature DB >> 19808065 |
Junjian Jiang1, Zhongwei Lv, Yudong Gu, Jifeng Li, Lei Xu, Wengdong Xu, Jiuzhuo Lu, Jianguang Xu.
Abstract
Bone marrow stromal stem cells (MSCs), which normally differentiate into mesenchymal derivatives, have recently reported to trans-differentiate into neurons. However, the findings from different groups and interpretations have been challenged. The purpose of this paper is to re-evaluate the phenomenon of neuronal trans-differentiation of MSCs and compare the expression levels of neurotrophins in rMSCs and neuronal-like phenotypes derived from rMSCs. We put rMSCs in 2-mercaptoethanol and 2% dimethylsulfoxide for 5h. Then, the cells were transferred to neuronal induction media composed of DMEM+10%FBS, 10ug/L basic fibroblast growth factor, 10ug/L human epidermal growth factor, 1mmol dibutyryl cyclicn AMP and 0.5mmol isobutylmethylxanthine for 7 days and 14 days. The study demonstrated that the level of BDNF, NGF, NT3, CNTF and GDNF of rMSCs is remarkably higher in rMSCs than the neuronal-like phenotypes, especially CNTF. The expression level of these neurotrophins did not change significantly after enduring induction. We believed that rMSCs can trans-differentiate into neuronal-like phenotype under certain conditions. The non-induced rMSCs has a dynamic expression profile of neurotrophins and may serves as a better tool than the trans-differentiated rMSCs for transplant therapy. Copyright 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19808065 DOI: 10.1016/j.neures.2009.09.1711
Source DB: PubMed Journal: Neurosci Res ISSN: 0168-0102 Impact factor: 3.304